Advertisement
Even if feds stop mega-mergers, new insurer transactions likely

Even if feds stop mega-mergers, new insurer transactions likely

By Bob Herman  |  July 23, 2016

Nearly everyone in healthcare speculated for the past year about how the U.S. Justice Department would respond to the mega-deals proposed by Aetna and Anthem. Officials were concise and stern as they delivered their answers from a podium last week.

Long-term costs of Zika among the many unknowns of the virus

Long-term costs of Zika among the many unknowns of the virus

By Shannon Muchmore  |  July 23, 2016

History buffs and infectious-disease experts have already drawn links between the rubella outbreak in the 1960s and the current spread of Zika. But drugmakers today face greater regulatory hurdles, and the federal government has yet to dedicate funding to address the Zika epidemic.

Physician Personals: Specialty group seeks primary-care practice

By Howard Wolinsky  |  July 23, 2016

The single life may prove troublesome for specialty group practices under MACRA. David Fitzgerald, CEO of Proliance Surgeons in suburban Seattle, said specialty practices are in the dark about their fate under the new physician reimbursement system.

Small practices need allies

Small practices need allies

By Howard Wolinsky  |  July 23, 2016

Dr. Joe Schlecht isn't afraid of MACRA, although he knows the design of the new Medicare payment system will be challenging for small practices like his. “Most primary-care physicians are still practicing like they did 10 years ago. They don't even know how to spell MACRA,” he said.

Why the Justice Department rejected the Aetna and Anthem deals

Why the Justice Department rejected the Aetna and Anthem deals

By Bob Herman  |  July 21, 2016

The government argues both transactions would “substantially lessen competition in numerous markets around the country.” The result, antitrust regulators said, would lead to “higher prices and reduced benefits” for consumers. Both companies plan to challenge the DOJ in court.

Costs of Zika among the many unknowns of the virus

Costs of Zika among the many unknowns of the virus

By Shannon Muchmore  |  July 20, 2016

History buffs and infectious-disease experts have already drawn links between the rubella outbreak in the 1960s and the current spread of Zika. But drugmakers today face greater regulatory hurdles, and the federal government has yet to dedicate funding to address the Zika epidemic.

Aetna, Anthem mega-deals appear headed for trouble

Aetna, Anthem mega-deals appear headed for trouble

By Bob Herman  |  July 19, 2016

The U.S. Justice Department is likely to file lawsuits this month to block Anthem's $53 billion acquisition of Cigna Corp. and Aetna's $37 billion deal for Humana, Bloomberg first reported Tuesday, citing anonymous sources.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.